🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/04/2017 1,51 1,59 1,50 1,51 +0,00% 5,83% 527.800
18/04/2017 1,56 1,58 1,44 1,51 -3,82% 8,97% 969.100
17/04/2017 1,58 1,64 1,56 1,57 -0,63% 5,06% 1.291.500
13/04/2017 1,66 1,68 1,57 1,58 -4,24% 6,63% 808.900
12/04/2017 1,68 1,69 1,64 1,65 -0,60% 2,68% 558.300
11/04/2017 1,62 1,68 1,62 1,66 +2,47% 3,77% 268.500
10/04/2017 1,67 1,67 1,62 1,62 -2,41% 2,99% 541.500
07/04/2017 1,69 1,70 1,65 1,66 -1,78% 2,96% 648.200
06/04/2017 1,67 1,71 1,61 1,69 +1,81% 5,99% 582.400
05/04/2017 1,70 1,80 1,62 1,66 -2,35% 10,59% 1.041.300
04/04/2017 1,80 1,83 1,67 1,70 -6,59% 9,17% 965.900
03/04/2017 1,86 1,93 1,81 1,82 -1,62% 6,45% 507.100
31/03/2017 1,87 1,90 1,85 1,85 -1,60% 2,67% 294.000
30/03/2017 1,94 1,95 1,86 1,88 -2,59% 4,59% 432.800
29/03/2017 1,81 1,94 1,80 1,93 +6,04% 7,73% 453.800
28/03/2017 1,90 1,91 1,80 1,82 -3,70% 5,79% 430.000
27/03/2017 1,85 1,93 1,83 1,89 +1,07% 5,14% 293.900
24/03/2017 1,87 1,93 1,83 1,87 +1,08% 5,35% 264.300
23/03/2017 1,83 1,88 1,78 1,85 +2,78% 5,46% 352.900
22/03/2017 1,84 1,86 1,75 1,80 -1,64% 5,98% 735.100
21/03/2017 1,97 1,99 1,82 1,83 -7,11% 8,78% 865.400
20/03/2017 2,04 2,08 1,97 1,97 -3,90% 5,39% 681.000
17/03/2017 2,05 2,10 2,03 2,05 -1,44% 3,41% 887.600
16/03/2017 2,14 2,19 2,04 2,08 -2,80% 6,82% 537.400
15/03/2017 2,13 2,15 2,03 2,14 +2,88% 5,40% 415.500
14/03/2017 2,12 2,14 2,04 2,08 -1,89% 4,72% 544.900
13/03/2017 2,15 2,15 2,08 2,12 +0,00% 3,26% 268.400
10/03/2017 2,16 2,20 2,07 2,12 +0,00% 6,02% 550.200
09/03/2017 2,15 2,18 2,10 2,12 -0,47% 3,72% 409.200
08/03/2017 2,09 2,21 2,07 2,13 +1,43% 6,70% 674.400